Hutchison China MediTech Limited Receives Buy Rating from Panmure Gordon (HCM)
Hutchison China MediTech Limited (LON:HCM)‘s stock had its “buy” rating reiterated by Panmure Gordon in a research note issued on Friday, Analyst Ratings Network reports. They currently have a GBX 600 ($9.68) price target on the stock. Panmure Gordon’s target price suggests a potential upside of 5.26% from the stock’s previous close.
Shares of Hutchison China MediTech Limited (LON:HCM) traded up 0.53% on Friday, hitting GBX 571.50. 6,413 shares of the company’s stock traded hands. Hutchison China MediTech Limited has a 52-week low of GBX 410.00 and a 52-week high of GBX 599.50. The stock’s 50-day moving average is GBX 559.4 and its 200-day moving average is GBX 519..
Hutchison China MediTech Limited (LON:HCM) is a holding company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.